Invesco Ltd. - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 97 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$28,472
-14.9%
22,071
+13.4%
0.00%
Q2 2023$33,468
+69.6%
19,458
+48.9%
0.00%
Q1 2023$19,728
-8.4%
13,065
-2.9%
0.00%
Q4 2022$21,538
-65.8%
13,461
-43.0%
0.00%
Q1 2022$63,000
-36.4%
23,628
+3.2%
0.00%
Q4 2021$99,000
-35.7%
22,899
-24.1%
0.00%
Q3 2021$154,000
-4.3%
30,175
+19.2%
0.00%
Q2 2021$161,000
+64.3%
25,325
+99.9%
0.00%
Q1 2021$98,000
-44.6%
12,668
-53.1%
0.00%
Q4 2020$177,000
+23.8%
27,034
+25.8%
0.00%
Q3 2020$143,000
-21.9%
21,482
-2.2%
0.00%
Q2 2020$183,000
-1.6%
21,976
-9.5%
0.00%
Q1 2020$186,000
-68.8%
24,293
-54.4%
0.00%
Q2 2019$597,000
-7.4%
53,241
-11.2%
0.00%
Q1 2019$645,000
-41.0%
59,954
-17.3%
0.00%
Q4 2018$1,094,000
-32.9%
72,474
-17.8%
0.00%
-100.0%
Q3 2018$1,631,000
-84.5%
88,151
-80.8%
0.00%
-66.7%
Q2 2018$10,500,000
-22.2%
459,297
-3.2%
0.00%
-40.0%
Q1 2018$13,499,000
+24.7%
474,498
-7.5%
0.01%
+25.0%
Q4 2017$10,829,000
+345.1%
512,994
+283.1%
0.00%
+300.0%
Q3 2017$2,433,000
+29.0%
133,916
+10.1%
0.00%0.0%
Q2 2017$1,886,000
+253.2%
121,683
+293.5%
0.00%
Q1 2017$534,00030,9250.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
BVF INC/IL 1,877,148$13,853,0001.46%
Congress Park Capital LLC 167,811$1,238,0001.04%
Perceptive Advisors 3,253,923$24,014,0000.65%
RTW INVESTMENTS, LP 990,463$7,310,0000.44%
Spark Investment Management LLC 337,164$2,488,0000.32%
Exane Asset Management 54,065$399,000,0000.31%
DAFNA Capital Management LLC 100,000$738,0000.28%
HARBOURVEST PARTNERS LLC 79,193$584,0000.24%
WELD CAPITAL MANAGEMENT LLC 86,363$637,0000.12%
GSA CAPITAL PARTNERS LLP 77,997$576,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders